Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.
News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.
Axcelis Technologies (Nasdaq: ACLS) will release its Q4 and FY 2021 financial results on February 7, 2022, at 4:00 p.m. ET. A conference call to discuss the results will follow at 5:00 p.m. ET, accessible via an audio webcast on the Axcelis website. Interested investors can dial in using 866.588.8911 (or 707.294.1561 internationally). Axcelis, based in Beverly, Mass., specializes in ion implantation systems for the semiconductor industry.
Axcelis Technologies (Nasdaq: ACLS) announced the shipment of multiple Purion M medium current implanters and a new evaluation tool to memory device makers. These shipments occurred in Q4 2021 and Q1 2022, showcasing strong demand for the Purion M platform. Executive VP Bill Bintz highlighted the platform's flexibility and continued strength in the memory and mature process technology markets as key growth drivers for 2022.
Axcelis Technologies (Nasdaq: ACLS) announced follow-on shipments of the Purion H200 SiC Power Series™ high current implanters to a major power device chipmaker in Asia and Europe during Q3 and Q4. Additionally, the company closed a Purion XE Power Series SiC high energy implanter evaluation for a new European customer. These systems will aid in high-volume production of SiC power devices for the automotive market. The SiC power device market is projected to grow at a 30% CAGR from 2019 to 2025, indicating strong demand for advanced semiconductor solutions.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 24th Annual Needham Virtual Growth Conference from January 10-14, 2022. Key executives, including Mary Puma and Kevin Brewer, will host a fireside chat on January 11 at 1:15 p.m. EST, with one-on-one meetings available. A live webcast of the presentation will be accessible via Axcelis' website and will be available for replay for 30 days post-event. This engagement highlights Axcelis' ongoing contributions to the semiconductor industry.
Axcelis Technologies, Inc. (Nasdaq: ACLS) has successfully completed a Purion H™ high current tool evaluation at a top advanced logic device manufacturer. This evaluation is expected to boost high-volume production capabilities for advanced logic devices. Bill Bintz, Executive VP of Product Development, emphasized the positive outlook for 2022 and 2023, citing opportunities for production buys. The Purion H features cutting-edge scanned spot beam technology that enhances device performance and yield while maintaining low operational costs.
Axcelis Technologies (NASDAQ: ACLS) announced its participation in the 10th Annual December CEO Summit on December 8, 2021, in San Francisco, CA. This event coincides with SEMICON West 2021 and involves small group meetings with 11 other companies, including ACM Research and Aehr Test. Attendance is by invitation only for accredited investors and research analysts, with a registration deadline of November 29. Presentation materials will be available on Axcelis' investor page. Proof of COVID vaccination is required for in-person attendees.
Axcelis Technologies (Nasdaq: ACLS) announced a Virtual Investor Day scheduled for December 9, 2021, from 12:00 p.m. ET to 2:00 p.m. ET. The event aims to engage the investment community and will feature presentations from the company's executive team focusing on future growth opportunities, followed by a Q&A session. All executive officers are expected to attend the event. For registration and more details, participants can visit investorday.axcelis.com. An archived version of the webcast will also be available post-event.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the SEMICON Japan 2021 exhibition, set for December 15-17 in Tokyo. The company will showcase its Purion™ and GSD Ovation™ Series of ion implanters at Booth #5731. The Purion Series is noted for its high purity and precision across various applications, while the GSD Ovation Series is designed for 200mm fab construction. CEO Mary Puma highlighted the importance of introducing advanced ion implant technologies to Japanese chipmakers to meet the growing demand in power devices and memory markets.
Axcelis Technologies (NASDAQ: ACLS), a leading supplier in the semiconductor sector, announced its participation in various investor conferences in November and December 2021. Key events include the Benchmark Company Technology Virtual Video 1x1 Investor Conference on November 17, the CEO Summit 2021 in San Francisco on December 8, the 2021 Virtual Investor Day on December 9, and the DA Davidson Semicap, Laser, and Optical Conference on December 15. These conferences provide a platform for management to engage with investors through virtual one-on-ones.
Axcelis Technologies, Inc. (Nasdaq: ACLS) reported strong financial results for Q3 2021, achieving revenue of $176.7 million, up from $147.3 million in Q2. The record system revenue of $126.2 million reflects growth in the implant systems segment. Net income rose to $27.5 million or $0.81 per diluted share, compared to $18.9 million or $0.55 in the previous quarter. The company anticipates approximately $190 million in revenue for Q4, with a gross margin expectation of 41.5%.